Cargando…

The decreased platelet-to-lymphocyte ratio could predict a good prognosis in patients with oligometastatic colorectal cancer: a single-center cohort retrospective study

BACKGROUND: Inflammation markers have an important effect on tumor proliferation, invasion, and metastasis. Oligometastatic disease (OMD) is an intermediate state between widespread metastases and locally confined disease, where curative strategies may be effective for some patients. We aimed to exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiaojuan, Cui, Jin, Li, Xiaohui, Liu, Chao, Sun, Jujie, Yue, Jinbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513170/
https://www.ncbi.nlm.nih.gov/pubmed/34645481
http://dx.doi.org/10.1186/s12957-021-02406-z
_version_ 1784583159142154240
author Huang, Xiaojuan
Cui, Jin
Li, Xiaohui
Liu, Chao
Sun, Jujie
Yue, Jinbo
author_facet Huang, Xiaojuan
Cui, Jin
Li, Xiaohui
Liu, Chao
Sun, Jujie
Yue, Jinbo
author_sort Huang, Xiaojuan
collection PubMed
description BACKGROUND: Inflammation markers have an important effect on tumor proliferation, invasion, and metastasis. Oligometastatic disease (OMD) is an intermediate state between widespread metastases and locally confined disease, where curative strategies may be effective for some patients. We aimed to explore the predictive value of inflammatory markers in patients with oligometastatic colorectal cancer (OMCC) and build a nomogram to predict the prognosis of these patients. METHODS: Two hundred nine patients with OMCC were retrospectively collected in this study. The Kaplan-Meier survival curves and Cox regression analysis were used to estimate overall survival (OS) and progression-free survival (PFS). A multivariate Cox analysis model was utilized to establish the nomogram. The concordance index (C-index), calibration curve, and receiver operating characteristics (ROC) were established to verify the validity and accuracy of the prediction model. RESULTS: According to the multivariate analysis, decreased platelet-to-lymphocyte ratio (PLR) might independently improve OS in patients with OMCC (HR = 2.396, 95% CI 1.391–4.126, P = 0.002). Metastases of extra-regional lymph nodes indicated poor OS (HR = 2.472, 95% CI 1.247–4.903, P = 0.010). While the patients with early N stage had better OS (HR = 4.602, 95% CI 2.055–10.305, P = 0.001) and PFS (HR = 2.100, 95% CI 1.364–3.231, P = 0.007). Primary tumor resection (HR = 0.367, 95% CI 0.148–0.908, P = 0.030) and lower fibrinogen (HR = 2.254, 95% CI 1.246–4.078, P = 0.007) could significantly prolong the OS in patients with OMCC. PLR, metastases of extra-regional lymph nodes, N stage, primary tumor resection, and fibrinogen were used to make up the nomogram. The C-index and area under the curve (AUC) of the ROC in nomogram were 0.721 and 0.772 respectively for OS, showed good consistency between predictive probability of OS and actual survival. CONCLUSIONS: Decreased PLR could predict a good prognosis in patients with OMCC. The nomogram including inflammatory factors and clinicopathological markers was credible and accurate to predict survivals in patients with OMCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12957-021-02406-z.
format Online
Article
Text
id pubmed-8513170
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85131702021-10-20 The decreased platelet-to-lymphocyte ratio could predict a good prognosis in patients with oligometastatic colorectal cancer: a single-center cohort retrospective study Huang, Xiaojuan Cui, Jin Li, Xiaohui Liu, Chao Sun, Jujie Yue, Jinbo World J Surg Oncol Research BACKGROUND: Inflammation markers have an important effect on tumor proliferation, invasion, and metastasis. Oligometastatic disease (OMD) is an intermediate state between widespread metastases and locally confined disease, where curative strategies may be effective for some patients. We aimed to explore the predictive value of inflammatory markers in patients with oligometastatic colorectal cancer (OMCC) and build a nomogram to predict the prognosis of these patients. METHODS: Two hundred nine patients with OMCC were retrospectively collected in this study. The Kaplan-Meier survival curves and Cox regression analysis were used to estimate overall survival (OS) and progression-free survival (PFS). A multivariate Cox analysis model was utilized to establish the nomogram. The concordance index (C-index), calibration curve, and receiver operating characteristics (ROC) were established to verify the validity and accuracy of the prediction model. RESULTS: According to the multivariate analysis, decreased platelet-to-lymphocyte ratio (PLR) might independently improve OS in patients with OMCC (HR = 2.396, 95% CI 1.391–4.126, P = 0.002). Metastases of extra-regional lymph nodes indicated poor OS (HR = 2.472, 95% CI 1.247–4.903, P = 0.010). While the patients with early N stage had better OS (HR = 4.602, 95% CI 2.055–10.305, P = 0.001) and PFS (HR = 2.100, 95% CI 1.364–3.231, P = 0.007). Primary tumor resection (HR = 0.367, 95% CI 0.148–0.908, P = 0.030) and lower fibrinogen (HR = 2.254, 95% CI 1.246–4.078, P = 0.007) could significantly prolong the OS in patients with OMCC. PLR, metastases of extra-regional lymph nodes, N stage, primary tumor resection, and fibrinogen were used to make up the nomogram. The C-index and area under the curve (AUC) of the ROC in nomogram were 0.721 and 0.772 respectively for OS, showed good consistency between predictive probability of OS and actual survival. CONCLUSIONS: Decreased PLR could predict a good prognosis in patients with OMCC. The nomogram including inflammatory factors and clinicopathological markers was credible and accurate to predict survivals in patients with OMCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12957-021-02406-z. BioMed Central 2021-10-13 /pmc/articles/PMC8513170/ /pubmed/34645481 http://dx.doi.org/10.1186/s12957-021-02406-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Huang, Xiaojuan
Cui, Jin
Li, Xiaohui
Liu, Chao
Sun, Jujie
Yue, Jinbo
The decreased platelet-to-lymphocyte ratio could predict a good prognosis in patients with oligometastatic colorectal cancer: a single-center cohort retrospective study
title The decreased platelet-to-lymphocyte ratio could predict a good prognosis in patients with oligometastatic colorectal cancer: a single-center cohort retrospective study
title_full The decreased platelet-to-lymphocyte ratio could predict a good prognosis in patients with oligometastatic colorectal cancer: a single-center cohort retrospective study
title_fullStr The decreased platelet-to-lymphocyte ratio could predict a good prognosis in patients with oligometastatic colorectal cancer: a single-center cohort retrospective study
title_full_unstemmed The decreased platelet-to-lymphocyte ratio could predict a good prognosis in patients with oligometastatic colorectal cancer: a single-center cohort retrospective study
title_short The decreased platelet-to-lymphocyte ratio could predict a good prognosis in patients with oligometastatic colorectal cancer: a single-center cohort retrospective study
title_sort decreased platelet-to-lymphocyte ratio could predict a good prognosis in patients with oligometastatic colorectal cancer: a single-center cohort retrospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513170/
https://www.ncbi.nlm.nih.gov/pubmed/34645481
http://dx.doi.org/10.1186/s12957-021-02406-z
work_keys_str_mv AT huangxiaojuan thedecreasedplatelettolymphocyteratiocouldpredictagoodprognosisinpatientswitholigometastaticcolorectalcancerasinglecentercohortretrospectivestudy
AT cuijin thedecreasedplatelettolymphocyteratiocouldpredictagoodprognosisinpatientswitholigometastaticcolorectalcancerasinglecentercohortretrospectivestudy
AT lixiaohui thedecreasedplatelettolymphocyteratiocouldpredictagoodprognosisinpatientswitholigometastaticcolorectalcancerasinglecentercohortretrospectivestudy
AT liuchao thedecreasedplatelettolymphocyteratiocouldpredictagoodprognosisinpatientswitholigometastaticcolorectalcancerasinglecentercohortretrospectivestudy
AT sunjujie thedecreasedplatelettolymphocyteratiocouldpredictagoodprognosisinpatientswitholigometastaticcolorectalcancerasinglecentercohortretrospectivestudy
AT yuejinbo thedecreasedplatelettolymphocyteratiocouldpredictagoodprognosisinpatientswitholigometastaticcolorectalcancerasinglecentercohortretrospectivestudy
AT huangxiaojuan decreasedplatelettolymphocyteratiocouldpredictagoodprognosisinpatientswitholigometastaticcolorectalcancerasinglecentercohortretrospectivestudy
AT cuijin decreasedplatelettolymphocyteratiocouldpredictagoodprognosisinpatientswitholigometastaticcolorectalcancerasinglecentercohortretrospectivestudy
AT lixiaohui decreasedplatelettolymphocyteratiocouldpredictagoodprognosisinpatientswitholigometastaticcolorectalcancerasinglecentercohortretrospectivestudy
AT liuchao decreasedplatelettolymphocyteratiocouldpredictagoodprognosisinpatientswitholigometastaticcolorectalcancerasinglecentercohortretrospectivestudy
AT sunjujie decreasedplatelettolymphocyteratiocouldpredictagoodprognosisinpatientswitholigometastaticcolorectalcancerasinglecentercohortretrospectivestudy
AT yuejinbo decreasedplatelettolymphocyteratiocouldpredictagoodprognosisinpatientswitholigometastaticcolorectalcancerasinglecentercohortretrospectivestudy